Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
about
Alzheimer mechanisms and therapeutic strategiesAnalysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individualsThe involvement of Reelin in neurodevelopmental disorders.Reelin Proteolysis Affects Signaling Related to Normal Synapse Function and NeurodegenerationThe airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's diseaseLoss of Reelin protects against atherosclerosis by reducing leukocyte-endothelial cell adhesion and lesion macrophage accumulationReelin and Neuropsychiatric Disorders.Reelin Signaling, Hippocampal Neurogenesis, and Efficacy of Aspirin Intake & Stem Cell Transplantation in Aging and Alzheimer's disease.More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegenerationRole of soluble epoxide hydrolase in age-related vascular cognitive decline.Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes.Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.Beta-amyloid impairs reelin signaling.A draft de novo genome assembly for the northern bobwhite (Colinus virginianus) reveals evidence for a rapid decline in effective population size beginning in the Late PleistoceneReelin-mediated Signaling during Normal and Pathological Forms of AgingGenomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.Preserved neurogenesis in non-demented individuals with AD neuropathology.Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.Overview and findings from the religious orders studyOverview and findings from the rush Memory and Aging ProjectReelin protects against amyloid β toxicity in vivoF-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice.Analysis of copy number variation in Alzheimer's disease: the NIALOAD/ NCRAD Family StudyMalignant synaptic growth and Alzheimer's disease.Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough.Longitudinal epidemiologic clinical-pathologic studies of aging and Alzheimer's disease.Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD).Neuropathological approaches to cerebral aging and neuroplasticity.The β-amyloid peptide compromises Reelin signaling in Alzheimer's disease.Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disordersReelin immunoreactivity in neuritic varicosities in the human hippocampal formation of non-demented subjects and Alzheimer's disease patients.Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.Relationship between genetic risk factors and markers for Alzheimer's disease pathology.Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease.Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies.Genome research in pre-dementia stages of Alzheimer's disease.Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.Genetic Comparison of Symptomatic and Asymptomatic Persons With Alzheimer Disease Neuropathology.State of Play in Alzheimer's Disease Genetics.
P2860
Q22252311-D89E0EF0-E436-4CFC-9155-29F9FAB69133Q24305513-B5684D0C-3499-486D-89E2-CD321C8CA107Q24632484-C8D48007-F405-48A7-8709-B26A22BBB953Q26749956-145DEECF-B9FE-4B5B-B2E6-63C4382A7E7AQ26991654-DD281439-DC50-40B2-82B3-2E542E3E7F0FQ27329447-991D6BEA-B28B-448B-B394-8BE9683FF12BQ28072540-D7E915C3-B5A7-4C35-B617-5A2EA71376D6Q34193235-C115145C-6918-4B16-8DDF-F3CC4991528DQ34557404-373DC27A-F653-4F62-A61B-3A25D9588195Q34622501-5532B77A-234E-4E80-9F7C-E38B8AC99CADQ34624775-BF356B80-9EDD-464A-9D0F-34A890D99C66Q34661700-B11A3F6F-056E-476E-82D4-198E55FC7301Q34951480-2C5C8AE8-5981-444B-AF0F-0E09BA98644AQ35118738-56B8D80E-2C80-4C73-AE22-8DA42F4949FBQ35806690-D75A3708-FA99-4A2A-8E30-13200BBAA656Q35852564-8298A07D-A024-429C-AB7C-5D8A3D2119A6Q36051333-3A3F95B8-2362-4112-8E37-F93B195C09AAQ36112830-9F830995-C083-4C53-A7C4-1F24D5DC8A92Q36130996-61869970-3AAA-43DD-9C0A-9433A08B3890Q36226167-0EEB20E5-E35C-4CFD-8342-1D5514EBCAEBQ36299546-5007F497-0CD6-4B02-89F9-7427830CA0DEQ36317638-CDC923E9-2829-4CC5-B37A-26F01EB54D0AQ36406509-CA4CC7A1-BBAC-49F6-8EB9-01C8CD68D5EBQ36607929-4994C81F-63D1-4F44-8A8D-D2AF07452518Q36612922-8E2F2FDB-127C-40A0-BDA8-B2F852C4737DQ36638822-5077C119-82E0-4A73-B83B-D0E7947985DEQ36713818-BA84DFF2-2405-4E83-99B9-B57A297E0DD7Q36755159-9B801E38-52B3-4152-A624-CB4DC5C1B6BBQ37181658-F2FA52B9-15A8-4B11-95FE-7A8282052537Q37199221-B4D2C189-9991-4415-9983-566B0F588F1FQ37485022-FE863559-9D01-4764-AF26-16DA84BF2804Q37981491-BDBD19BF-8817-4F71-B7C6-8A1EFC1E714CQ38037159-29FE81FF-A4C3-42C8-9A8D-276373F1B0EAQ38088622-3C189CCB-2E0F-4108-B7E8-9021F598C098Q38836837-23F083D6-0A77-4D2C-8F9D-662A84651C71Q38847374-4C35098D-9212-4912-B43F-3DB1FECFE27AQ38879090-D4C98EDB-40DD-4A33-AEE6-EE0DB55C7362Q39037584-978B2087-0FDF-41D1-BC16-0649BB3999ABQ39183650-C0C490A8-AE39-441D-AA9A-58AC4912215AQ39307376-A345F1D3-2E28-44AE-8464-1862817383AE
P2860
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
description
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im Dezember 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2011/12/01)
@nl
наукова стаття, опублікована в грудні 2011
@uk
مقالة علمية (نشرت في ديسمبر 2011)
@ar
name
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
@ast
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
@en
type
label
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
@ast
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
@en
prefLabel
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
@ast
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
@en
P2093
P2860
P50
P3181
P1476
Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study
@en
P2093
David A. Bennett
David Clark
Deniz Erten-Lyons
Douglas Galasko
Jeffrey A. Kaye
John C. Morris
Juan C. Troncoso
Kathleen A. Welsh-Bohmer
P2860
P304
P3181
P356
10.1016/J.NEUROBIOLAGING.2010.01.010
P577
2011-12-01T00:00:00Z